Literature DB >> 7855469

Age-related reference ranges: significance tests for models and confidence intervals for centiles.

A M Wade1, A E Ades.   

Abstract

A method of fitting age-related reference ranges using maximized likelihood is presented. The method is illustrated using CD4 counts of uninfected children born to HIV-1 infected women. The likelihood incorporates exponential functions to describe the Box-Cox transformation parameter that induces Normality and the mean and standard deviation of the transformed data, at all ages in the range. This guarantees that the centiles are asymptotic to notional adult values and avoids edge effects. Likelihood ratio tests were used to assess the significance of the model parameters, and profile likelihood confidence intervals were constructed around the fitted centiles. The asymptotes of the resulting CD4 reference range for the childhood dataset were compared with CD4 counts available from a group of uninfected adults. The proposed approach limits the need for arbitrary decisions about grouping of the data, degree of smoothing or choice of model.

Entities:  

Mesh:

Year:  1994        PMID: 7855469     DOI: 10.1002/sim.4780132207

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  14 in total

1.  Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.

Authors:  Adeodata Kekitiinwa; Alexander J Szubert; Moira Spyer; Richard Katuramu; Victor Musiime; Tawanda Mhute; Sabrina Bakeera-Kitaka; Oscar Senfuma; Ann Sarah Walker; Diana M Gibb
Journal:  Pediatr Infect Dis J       Date:  2017-06       Impact factor: 2.129

2.  Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets.

Authors:  Andrzej Bienczak; Paolo Denti; Adrian Cook; Lubbe Wiesner; Veronica Mulenga; Cissy Kityo; Addy Kekitiinwa; Diana M Gibb; David Burger; Ann S Walker; Helen McIlleron
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

3.  Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial.

Authors: 
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

4.  Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.

Authors:  Ali Judd
Journal:  AIDS       Date:  2011-11-28       Impact factor: 4.177

5.  Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.

Authors:  Marie-Quitterie Picat; Joanna Lewis; Victor Musiime; Andrew Prendergast; Kusum Nathoo; Addy Kekitiinwa; Patricia Nahirya Ntege; Diana M Gibb; Rodolphe Thiebaut; A Sarah Walker; Nigel Klein; Robin Callard
Journal:  PLoS Med       Date:  2013-10-29       Impact factor: 11.069

6.  Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.

Authors:  Mutsawashe Bwakura-Dangarembizi; Victor Musiime; Alexander J Szubert; Andrew J Prendergast; Zvenyika A Gomo; Margaret J Thomason; Cuthbert Musarurwa; Peter Mugyenyi; Patricia Nahirya; Adeodata Kekitiinwa; Diana M Gibb; Ann S Walker; Kusum Nathoo
Journal:  Pediatr Infect Dis J       Date:  2015-02       Impact factor: 2.129

7.  Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Authors: 
Journal:  Lancet       Date:  2013-03-07       Impact factor: 79.321

8.  Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

Authors:  Angela M Crook; Anna Turkova; Victor Musiime; Mutsa Bwakura-Dangarembizi; Sabrina Bakeera-Kitaka; Patricia Nahirya-Ntege; Margaret Thomason; Peter Mugyenyi; Philippa Musoke; Adeodata Kekitiinwa; Paula Munderi; Kusum Nathoo; Andrew J Prendergast; A Sarah Walker; Diana M Gibb
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

9.  Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children.

Authors:  Andrzej Bienczak; Paolo Denti; Adrian Cook; Lubbe Wiesner; Veronica Mulenga; Cissy Kityo; Addy Kekitiinwa; Diana M Gibb; David Burger; A Sarah Walker; Helen McIlleron
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

10.  Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial.

Authors:  Joanna Lewis; Helen Payne; A Sarah Walker; Kennedy Otwombe; Diana M Gibb; Abdel G Babiker; Ravindre Panchia; Mark F Cotton; Avy Violari; Nigel Klein; Robin E Callard
Journal:  Front Immunol       Date:  2017-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.